Join us for the 2021 CurePSP International Research Symposium featuring leaders from academia and industry in clinical and preclinical science relevant to PSP, CBD, and tauopathies!
CurePSP conducts an International Research Symposium that brings together international investigators to hear about and discuss the latest scientific advances relevant to neurodegeneration with a particular focus on rare tauopathies such as PSP and CBD. The Symposium highlights research by leading neuroscientists and welcomes all researchers with an interest in preclinical and clinical neuroscience. This year, this event will be fully virtual!
- Michael Ahlijanian, Pinteon Inc, Cambridge, Massachusetts (USA)
- Adam Boxer, University of California, San Francisco, California (USA)*
- Tim Buchanan, UCB Pharma, Brussels, (Belgium)
- John Crary, Mount Sinai, New York (USA)
- Lawrence Golbe, Rutgers University, New Jersey (USA)
- Huw Morris, University College London, London (United Kingdom)
- Ana Pereira, Mount Sinai, New York (USA)
- Gil Rabinovici, University of California, San Francisco, California (USA)
- Judith Steen, Harvard Medical School, Boston, Massachusetts (USA)
- Sally Temple, Neural Stem Cell Institute, Rensselaer, New York (USA)*
- Lucia Wille, Applied BioMath, Cambridge, Massachusetts (USA)
- Nasser Zawia, NeuroTau, Warwick, Rhode Island (USA))
Agenda and additional speakers to be announced. *Keynote speakers.
This event will be recorded and accessible via a secure portal after the event. The secure conference portal will be accessible to registrants until May 2021.
This Event Supported in Part by: